Related Experiment Video

Updated: Mar 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.7K

Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer

Virginia Campani1, Giuseppina Salzano2, Sara Lusa3

  • 1Department of Pharmacy, University Federico II of Naples, Via Domenico Montesano 49, 80131 Naples, Italy. virginia.campani@unina.it.

Nanomaterials (Basel, Switzerland)
|March 25, 2017
PubMed

Insights

Lipid nanovectors show promise for delivering non-coding RNAs (ncRNA) to treat cancer by overcoming delivery challenges. These biocompatible nanoparticles enhance the therapeutic potential of small interfering RNA (siRNA) and microRNA (miRNA) in cancer treatment.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Background:

  • Gene silencing and regulation by non-coding RNAs (ncRNA), including small interfering RNA (siRNA) and microRNA (miRNA), are crucial for cancer development.
  • RNA-based therapeutics offer significant potential for cancer treatment but face biopharmaceutical delivery challenges.

Purpose of the Study:

  • To review and discuss lipid nanovectors as a strategy for delivering ncRNA in cancer therapy.
  • To analyze the rational design and reported outcomes of various lipid nanovector delivery systems for ncRNA.

Main Methods:

  • Literature review of studies investigating lipid nanovectors for ncRNA delivery.
  • Analysis of in vitro and in vivo data for different lipid nanovector formulations.
  • Discussion of the advantages of lipid-based biomaterials for RNA delivery.

Main Results:

  • Lipid nanovectors are effective in delivering RNA for various cancer types.
  • Lipids offer advantages like biocompatibility, biodegradability, low cost, and reduced toxicity compared to other biomaterials.
  • Nanovector formulation overcomes RNA biopharmaceutical issues and enables tumor targeting.

Conclusions:

  • Lipid nanovectors represent a promising strategy for overcoming delivery challenges in RNA-based cancer therapeutics.
  • Further research into rational design and evaluation of lipid nanovectors is essential for advancing ncRNA cancer therapy.
Keywords:
cationic liposomeslipid-nanoparticlesmicellesnucleic acidstable nucleic acid lipid particles (SNALPs)

More Related Videos

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.7K
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K